+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes



Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes



Oncotarget 5(20): 9864-9876



Accumulating evidence highlights the potential role of long non-coding RNAs (lncRNAs) as biomarkers and therapeutic targets in solid tumors. However, the role of lncRNA expression in human breast cancer biology, prognosis and molecular classification remains unknown. Herein, we established the lncRNA profile of 658 infiltrating ductal carcinomas of the breast from The Cancer Genome Atlas project. We found lncRNA expression to correlate with the gene expression and chromatin landscape of human mammary epithelial cells (non-transformed) and the breast cancer cell line MCF-7. Unsupervised consensus clustering of lncRNA revealed four subgroups that displayed different prognoses. Gene set enrichment analysis for cis- and trans-acting lncRNAs showed enrichment for breast cancer signatures driven by master regulators of breast carcinogenesis. Interestingly, the lncRNA HOTAIR was significantly overexpressed in the HER2-enriched subgroup, while the lncRNA HOTAIRM1 was significantly overexpressed in the basal-like subgroup. Estrogen receptor (ESR1) expression was associated with distinct lncRNA networks in lncRNA clusters III and IV. Importantly, almost two thirds of the lncRNAs were marked by enhancer chromatin modifications (i.e., H3K27ac), suggesting that expressed lncRNA in breast cancer drives carcinogenesis through increased activity of neighboring genes. In summary, our study depicts the first lncRNA subtype classification in breast cancer and provides the framework for future studies to assess the interplay between lncRNAs and the breast cancer epigenome.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052269818

Download citation: RISBibTeXText

PMID: 25296969


Related references

Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer. Bmc Systems Biology 8: 83, 2015

Microarray expression profile analysis of long non-coding RNAs in human breast cancer: a study of Chinese women. Biomedicine and PharmacoTherapy 69: 221-227, 2015

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer. Breast Cancer Research 18(1): 33, 2016

Comprehensive analysis of long non-coding RNAs in ovarian cancer reveals global patterns and targeted DNA amplification. Plos One 8(11): E80306, 2014

Comprehensive analysis of differentially expressed profiles of long non-coding RNAs and messenger RNAs in kaolin-induced hydrocephalus. Gene 2019, 2019

Current Status of Long Non-Coding RNAs in Human Breast Cancer. International Journal of Molecular Sciences 17(9), 2017

Long non-coding RNAs as prognostic markers in human breast cancer. Oncotarget 7(15): 20584-20596, 2018

Long Non-Coding RNA TUG1 Expression Is Associated with Different Subtypes in Human Breast Cancer. Non-Coding Rna 3(4), 2018

Long Non-coding RNAs Contribute to the Inhibition of Proliferation and EMT by Pterostilbene in Human Breast Cancer. Frontiers in Oncology 8: 629-629, 2019

Comprehensive analysis of coexpressed long noncoding RNAs and genes in breast cancer. Journal of Obstetrics and Gynaecology Research 2018, 2018

Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes. Plos One 9(9): E106076, 2015

Discovering DNA methylation patterns for long non-coding RNAs associated with cancer subtypes. Computational Biology and Chemistry 69: 164-170, 2017

Concise approach for screening long non-coding RNAs functionally linked to human breast cancer associated genes. Experimental and Molecular Pathology 2019, 2019

Upregulated long non-coding RNAs demonstrate promising efficacy for breast cancer detection: a meta-analysis. Oncotargets and Therapy 11: 1491-1499, 2018

Integrated analysis of long non-coding RNAs in human colorectal cancer. Oncotarget 7(17): 23897-23908, 2018